FRM
BNTX icon

Fox Run Management’s BioNTech BNTX Stock Holding History

Fox Run Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,750
Closed -$962K – 931
2025
Q3 		$962K Buy
9,750
+6,906
+243% +$738K 0.15% 228
2025
Q2 		$303K Buy
+2,844
New +$287K 0.05% 634
2024
Q3 		– Sell
-8,183
Closed -$658K – 817
2024
Q2 		$658K Buy
+8,183
New +$748K 0.12% 312
2023
Q4 		– Sell
-7,921
Closed -$861K – 741
2023
Q3 		$861K Buy
+7,921
New +$876K 0.25% 107
2022
Q3 		– Sell
-1,542
Closed -$230K – 614
2022
Q2 		$230K Sell
1,542
-118
-7% -$18K 0.11% 383
2022
Q1 		$283K Buy
+1,660
New +$279K 0.16% 296

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fox Run Management's BNTX Position: Q4 2025 in Review

Fox Run Management sold out of BioNTech (BNTX) in Q4 2025, closing a stake of 9,750 shares — an estimated $962K sold.

Fox Run Management first reported a position in BNTX in Q1 2022 and held it in 6 quarters. The position peaked at $962K in Q3 2025. 284 funds tracked by Wall St. Rank hold BNTX as of Q4 2025.

  • Fox Run Management reported no remaining BioNTech position as of Q4 2025 after selling out during the quarter.
  • Fox Run Management sold 9,750 BioNTech shares in Q4 2025, an estimated $962K.
  • Fox Run Management first reported a position in BioNTech in Q1 2022 and held it in 6 quarters.
  • Fox Run Management's BioNTech position peaked at $962K in Q3 2025.
  • 284 funds tracked by Wall St. Rank held BioNTech as of Q4 2025.

Based on Fox Run Management's 13F filing for Q4 2025, filed 11 Feb 2026.